Aker BioMarine ASA (OSL:AKBM) Research & Development : kr0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aker BioMarine ASA's Research & Development for the three months ended in Mar. 2024 was kr0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr0 Mil.

Aker BioMarine ASA Research & Development Historical Data

The historical data trend for Aker BioMarine ASA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Research & Development Chart

Aker BioMarine ASA Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

48.77

34.00

26.94

39.52

4.22

Aker BioMarine ASA Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Aker BioMarine ASA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

Aker BioMarine ASA (OSL:AKBM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aker BioMarine ASA Research & Development Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Aker BioMarine ASA (OSL:AKBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

1PG:Germany

Address

Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327

Website

https://www.akerbiomarine.com

Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines